264 related articles for article (PubMed ID: 8940412)
1. In vivo and in vitro characterization of antalarmin, a nonpeptide corticotropin-releasing hormone (CRH) receptor antagonist: suppression of pituitary ACTH release and peripheral inflammation.
Webster EL; Lewis DB; Torpy DJ; Zachman EK; Rice KC; Chrousos GP
Endocrinology; 1996 Dec; 137(12):5747-50. PubMed ID: 8940412
[TBL] [Abstract][Full Text] [Related]
2. Chronic effects of a nonpeptide corticotropin-releasing hormone type I receptor antagonist on pituitary-adrenal function, body weight, and metabolic regulation.
Bornstein SR; Webster EL; Torpy DJ; Richman SJ; Mitsiades N; Igel M; Lewis DB; Rice KC; Joost HG; Tsokos M; Chrousos GP
Endocrinology; 1998 Apr; 139(4):1546-55. PubMed ID: 9528933
[TBL] [Abstract][Full Text] [Related]
3. Effects of a novel corticotropin-releasing-hormone receptor type I antagonist on human adrenal function.
Willenberg HS; Bornstein SR; Hiroi N; Päth G; Goretzki PE; Scherbaum WA; Chrousos GP
Mol Psychiatry; 2000 Mar; 5(2):137-41. PubMed ID: 10822340
[TBL] [Abstract][Full Text] [Related]
4. Corticotropin releasing hormone (CRH) antagonist attenuates adjuvant induced arthritis: role of CRH in peripheral inflammation.
Webster EL; Barrientos RM; Contoreggi C; Isaac MG; Ligier S; Gabry KE; Chrousos GP; McCarthy EF; Rice KC; Gold PW; Sternberg EM
J Rheumatol; 2002 Jun; 29(6):1252-61. PubMed ID: 12064844
[TBL] [Abstract][Full Text] [Related]
5. The impact of the nonpeptide corticotropin-releasing hormone antagonist antalarmin on behavioral and endocrine responses to stress.
Deak T; Nguyen KT; Ehrlich AL; Watkins LR; Spencer RL; Maier SF; Licinio J; Wong ML; Chrousos GP; Webster E; Gold PW
Endocrinology; 1999 Jan; 140(1):79-86. PubMed ID: 9886810
[TBL] [Abstract][Full Text] [Related]
6. Corticotropin-releasing hormone antagonists, astressin B and antalarmin: differing profiles of activity in rhesus monkeys.
Broadbear JH; Winger G; Rivier JE; Rice KC; Woods JH
Neuropsychopharmacology; 2004 Jun; 29(6):1112-21. PubMed ID: 14997174
[TBL] [Abstract][Full Text] [Related]
7. A specific CRH antagonist attenuates ACTH-stimulated cortisol secretion in ovine adrenocortical cells.
Valego NK; Rose JC
Reprod Sci; 2010 May; 17(5):477-86. PubMed ID: 20220106
[TBL] [Abstract][Full Text] [Related]
8. Effect of antalarmin, a novel corticotropin-releasing hormone antagonist, on the dynamic function of the preterm ovine fetal hypothalamo-pituitary-adrenal axis.
Young IR; Chan EC; Smith R; Chrousos GP; Veldhuis JD; Canny BJ
Neuroendocrinology; 2002 Jul; 76(1):47-54. PubMed ID: 12097816
[TBL] [Abstract][Full Text] [Related]
9. A corticotropin-releasing hormone type I receptor antagonist delays parturition in sheep.
Chan EC; Falconer J; Madsen G; Rice KC; Webster EL; Chrousos GP; Smith R
Endocrinology; 1998 Jul; 139(7):3357-60. PubMed ID: 9645712
[TBL] [Abstract][Full Text] [Related]
10. Corticotropin-releasing hormone and inflammation.
Webster EL; Torpy DJ; Elenkov IJ; Chrousos GP
Ann N Y Acad Sci; 1998 May; 840():21-32. PubMed ID: 9629233
[TBL] [Abstract][Full Text] [Related]
11. Effects of corticotropin-releasing hormone receptor antagonists on the ethanol-induced increase of dynorphin A1-8 release in the rat central amygdala.
Lam MP; Gianoulakis C
Alcohol; 2011 Nov; 45(7):621-30. PubMed ID: 21840158
[TBL] [Abstract][Full Text] [Related]
12. Chronic administration of the non-peptide CRH type 1 receptor antagonist antalarmin does not blunt hypothalamic-pituitary-adrenal axis responses to acute immobilization stress.
Wong ML; Webster EL; Spokes H; Phu P; Ehrhart-Bornstein M; Bornstein S; Park CS; Rice KC; Chrousos GP; Licinio J; Gold PW
Life Sci; 1999; 65(4):PL53-8. PubMed ID: 10421433
[TBL] [Abstract][Full Text] [Related]
13. Reduced hypothalamic vasopressin secretion underlies attenuated adrenocorticotropin stress responses in pregnant rats.
Ma S; Shipston MJ; Morilak D; Russell JA
Endocrinology; 2005 Mar; 146(3):1626-37. PubMed ID: 15591137
[TBL] [Abstract][Full Text] [Related]
14. Antalarmin blockade of corticotropin releasing hormone-induced hypertension in rats.
Briscoe RJ; Cabrera CL; Baird TJ; Rice KC; Woods JH
Brain Res; 2000 Oct; 881(2):204-7. PubMed ID: 11036160
[TBL] [Abstract][Full Text] [Related]
15. Behavioral, adrenal, and sympathetic responses to long-term administration of an oral corticotropin-releasing hormone receptor antagonist in a primate stress paradigm.
Ayala AR; Pushkas J; Higley JD; Ronsaville D; Gold PW; Chrousos GP; Pacak K; Calis KA; Gerald M; Lindell S; Rice KC; Cizza G
J Clin Endocrinol Metab; 2004 Nov; 89(11):5729-37. PubMed ID: 15531536
[TBL] [Abstract][Full Text] [Related]
16. Antalarmin, a putative CRH-RI antagonist, has transient reinforcing effects in rhesus monkeys.
Broadbear JH; Winger G; Rice KC; Woods JH
Psychopharmacology (Berl); 2002 Nov; 164(3):268-76. PubMed ID: 12424550
[TBL] [Abstract][Full Text] [Related]
17. Antagonizing the corticotropin releasing hormone receptor 1 with antalarmin reduces the progression of endometriosis.
Torres-Reverón A; Rivera-Lopez LL; Flores I; Appleyard CB
PLoS One; 2018; 13(11):e0197698. PubMed ID: 30427841
[TBL] [Abstract][Full Text] [Related]
18. Receptors and actions of corticotropin-releasing hormone in the primate pituitary gland.
Millan MA; Samra AB; Wynn PC; Catt KJ; Aguilera G
J Clin Endocrinol Metab; 1987 May; 64(5):1036-41. PubMed ID: 3031117
[TBL] [Abstract][Full Text] [Related]
19. Divergent roles of the CRH receptors in the control of gonadotropin secretion induced by acute restraint stress at proestrus.
Traslaviña GA; Franci CR
Endocrinology; 2012 Oct; 153(10):4838-48. PubMed ID: 22893722
[TBL] [Abstract][Full Text] [Related]
20. Corticotropin releasing hormone receptors: two decades later.
Aguilera G; Nikodemova M; Wynn PC; Catt KJ
Peptides; 2004 Mar; 25(3):319-29. PubMed ID: 15134857
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
